Adverse reactions to meglumine antimoniate in Brazilian inpatients with visceral leishmaniases: A case series.

Áquila Serbate Borges Portela Caryne Margotto Bertollo Marcus Fernando da Silva Praxedes Sandro Aurélio Silva Brasileiro Adriano Max Moreira Reis Maria Auxiliadora Parreiras Martins

Published in: Journal of clinical pharmacy and therapeutics (2019)

Meglumine antimoniate is highly toxic. Adherence to treatment guidelines is important. Pharmacists working in multidisciplinary teams may contribute to early detection and management of MA therapy-related ADR.

Keyphrases

adverse drug
insulin resistance
clinical practice
emergency department
primary care
stem cells
replacement therapy
quality improvement
metabolic syndrome
adipose tissue
general practice
skeletal muscle
cell therapy
mesenchymal stem cells